Qingbo Xu

机构：Zhengzhou University, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0002-6414-2273

发表论文 90 篇 · 总被引 3763 次 · h-index 25

代表论文

• Endothelial and smooth muscle cell transformation in atherosclerosis (2015 · Current Opinion in Lipidology · 被引 81)
• CD34 + cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis (2023 · Science Advances · 被引 47)
• Comparative analysis of thoracic and abdominal aortic aneurysms across the segment and species at the single-cell level (2023 · Frontiers in Pharmacology · 被引 35)
• Inhibition of 5‐Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β‐Arrestin2–Mammalian Target of Rapamycin/p70S6K Pathway (2018 · Journal of the American Heart Association · 被引 28)
• Lymphatics in Cardiovascular Disease (2020 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 27)
• CD248-targeted BBIR-T cell therapy against late-activated fibroblasts in cardiac repair after myocardial infarction (2025 · Nature Communications · 被引 25)